[Present views on therapy with growth hormone].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3168051)

Published in Cesk Pediatr on August 01, 1988

Authors

J Lebl, J Vavrinec, M Snajderová, S Kolousková

Articles by these authors

Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia (2005) 1.60

[Glibenclamide instead of insulin: a new chance for MODY 3 type diabetes patients: case report]. Vnitr Lek (2006) 1.42

[Association of insulin gene variants with type 1 diabetes mellitus in Czech population]. Cas Lek Cesk (2004) 1.39

Tumor risk in disorders of sex development. Sex Dev (2010) 1.17

Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes. J Clin Virol (2006) 1.11

Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents. Eur J Pediatr (2006) 1.11

The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome. Eur J Endocrinol (2001) 1.09

Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol (2005) 1.09

Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study. Horm Res (2001) 1.06

Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. J Clin Endocrinol Metab (2011) 1.03

Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha. Diabetologia (2003) 1.03

Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study. Diabetes Res Clin Pract (2004) 0.93

HLA-DQA1*05-DQB1*0201 positivity predisposes to coeliac disease in Czech diabetic children. Acta Paediatr (2000) 0.92

Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED. Hum Mutat (2001) 0.90

Type 1 diabetes mellitus in Czech children diagnosed in 1990-1997: a significant increase in incidence and male predominance in the age group 0-4 years. Collaborators of the Czech Childhood Diabetes Registry. Diabet Med (2000) 0.88

HLA class II genetic association of type 1 diabetes mellitus in Czech children. Pediatr Diabetes (2001) 0.86

The CTLA4 +49 A/G dimorphism is not associated with type 1 diabetes in Czech children. Eur J Immunogenet (2002) 0.85

[Pregnancy and delivery after traumatic panhypopituitarism]. Ceska Gynekol (2003) 0.84

Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius. J Clin Endocrinol Metab (2013) 0.83

HLA-DQ polymorphisms modify the risk of thyroid autoimmunity in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab (2003) 0.83

The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus. Diabet Med (2013) 0.82

Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. J Clin Endocrinol Metab (2001) 0.81

Six novel mutations in the GCK gene in MODY patients. Clin Genet (2007) 0.81

Congenital adrenal hyperplasia: lessons from a multinational study. Horm Res (2002) 0.81

Thyroid autoimmunity in children with coexisting type 1 diabetes mellitus and celiac disease: a multicenter study. J Pediatr Endocrinol Metab (2006) 0.80

Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. J Pediatr Adolesc Gynecol (1999) 0.80

45,X/46,X,psu dic(Y) gonadal dysgenesis: influence of the two cell lines on the clinical phenotype, including gonadal histology. Sex Dev (2013) 0.80

[Parental attitudes and socio-emotional development in children born after ICSI]. Ceska Gynekol (2008) 0.79

An in vitro skin explant assay as a predictive assay for graft-versus-host disease in a cohort of pediatric transplants. Pediatr Transplant (2001) 0.79

GH and TSH deficiency. Exp Clin Endocrinol Diabetes (1997) 0.79

Bone geometry and volumetric bone density at the radius in patients with isolated SHOX deficiency. Exp Clin Endocrinol Diabetes (2013) 0.79

Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants - effect of GVHD prophylaxis. Bone Marrow Transplant (1999) 0.78

[Disorders of sex differentiation: genes responsible for development of genital system and final phenotype]. Ceska Gynekol (2009) 0.78

Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1. Diabetologia (2011) 0.78

Higher maternal age at delivery, and lower birth orders are associated with increased risk of childhood type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes (2004) 0.77

Lack of PAX4 mutations in 53 Czech MODYX families. Diabet Med (2010) 0.77

[The contrast sensitivity test in early detection of ocular changes in children, teenagers, and young adults with diabetes mellitus type I]. Cesk Slov Oftalmol (2006) 0.77

Boys with haemophilia have low trabecular bone mineral density and sarcopenia, but normal bone strength at the radius. Haemophilia (2011) 0.77

[The human lens' transparence changes in children, adolescents, and young adults with diabetes mellitus type I]. Cesk Slov Oftalmol (2006) 0.77

Validation of a mathematical model predicting the response to growth hormone treatment in prepubertal children with idiopathic growth hormone deficiency. Horm Res (2003) 0.77

Body composition in children receiving recombinant human growth hormone after renal transplantation. Kidney Int (1998) 0.76

[The effect of enalapril on the development of diabetic nephropathy in children and adolescents]. Cesk Pediatr (1991) 0.76

[Childhood diabetes in the Czech Republic: a steady increase in incidence]. Cas Lek Cesk (2005) 0.76

Artificially low cortical bone mineral density in Turner syndrome is due to the partial volume effect. Osteoporos Int (2014) 0.76

[Growth and adult height in patients with congenital adrenal hyperplasia]. Cas Lek Cesk (1995) 0.76

Treatment options for children with monogenic forms of obesity. World Rev Nutr Diet (2013) 0.76

Desmopressin in a long-term treatment of children with primary nocturnal enuresis--a symptomatic therapy? Eur J Pediatr (2001) 0.75

[Prediction of type 1 diabetes mellitus in first degree Czech relatives of diabetic patients]. Vnitr Lek (2002) 0.75

An analysis of the relationship between insulin resistance and the activity of steroid C17,20-lyase and 3beta-hydroxysteroid dehydrogenase in ovaries and adrenals in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2000) 0.75

Severe hypoglycemia and reduction of insulin requirement in a girl with insulin-dependent diabetes mellitus: first sign of a craniopharyngioma. J Pediatr Endocrinol Metab (2000) 0.75

[The effect of food supplementation with organically bound chromium on indicators of compensation in diabetic children and adolescents]. Cesk Pediatr (1992) 0.75

[Late sequelae of comprehensive antineoplastic therapy in children and adolescents with solid extracranial tumors. Effect on growth, pubertal development and gonadal function]. Cas Lek Cesk (1997) 0.75

[Disorders of sexual development (2 case report, delayed diagnosis)]. Cesk Pediatr (1990) 0.75

[The effect of growth hormone therapy on thyroid parameters]. Cesk Pediatr (1994) 0.75

[Cyproterone acetate in the treatment of girls with central precocious puberty]. Cesk Pediatr (1991) 0.75

[Late (non-classic) adrenal hyperplasia]. Ceska Gynekol (2007) 0.75

[Use of modern methods in prenatal diagnosis of congenital adrenal hyperplasia--examination protocol]. Cesk Pediatr (1992) 0.75

[Prediction of insulin-dependent diabetes mellitus in children of first-degree relatives of diabetic patients]. Cas Lek Cesk (2001) 0.75

[Long-term therapy of central precocious puberty in girls with the gonadoliberin analog D-Trp-6-LHRH after prior therapy with cyproterone acetate]. Cesk Pediatr (1994) 0.75

[Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog]. Cesk Pediatr (1994) 0.75

[Differential diagnosis in children with small stature]. Cas Lek Cesk (1995) 0.75

[A laboratory test for the detection of androgen resistance using sex hormone-binding globulin]. Vnitr Lek (1992) 0.75

[Diagnosis of growth hormone deficiency: present state and perspectives]. Cesk Pediatr (1991) 0.75

[Determination of the renal threshold for glucose excretion in diabetic children]. Cesk Pediatr (1988) 0.75

[Psychomotor and cognitive development of children born after intracytoplasmic sperm injection]. Ceska Gynekol (2008) 0.75

[Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes]. Cas Lek Cesk (2000) 0.75

[A portable apparatus for capillary blood collection]. Cesk Pediatr (1990) 0.75

[Growth in children with the exudative enteropathy syndrome due to a congenital heart defect--cor triatriatum dextrum]. Cas Lek Cesk (1996) 0.75

[Ureter triplex]. Rozhl Chir (1971) 0.75

[Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome]. Cas Lek Cesk (2001) 0.75

[Growth hormone therapy in children with growth hormone deficiency: study of dose-response relationship]. Cas Lek Cesk (1994) 0.75

Evaluation of SHBG test for disclosure of insensitivity to androgens. Endocr Regul (1993) 0.75

[What do we owe the families of diabetic children?]. Cesk Pediatr (1989) 0.75

[The importance of strict control of blood glucose at the onset and during the remission stage in newly diagnosed diabetic children]. Cesk Pediatr (1988) 0.75

[Prenatal diagnosis of congenital adrenal hyperplasia and possibilities of prenatal therapy]. Cesk Pediatr (1992) 0.75

[The effect of treatment on growth in children with central precocious puberty]. Cas Lek Cesk (1995) 0.75